Investigation of sildenafil in the treatment of prostatitis-related sexual dysfunction.
- Author:
Shaobo YANG
1
;
Yili LIU
;
Chuize KONG
;
Ming LI
Author Information
- Publication Type:Clinical Trial
- MeSH: Adult; Anxiety; drug therapy; Humans; Male; Middle Aged; Piperazines; therapeutic use; Prostatitis; complications; Purines; Sexual Dysfunctions, Psychological; drug therapy; Sildenafil Citrate; Sulfones
- From: National Journal of Andrology 2004;10(6):451-454
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the value of sildenafil in the treatment of prostatitis-related sexual dysfunction.
METHODSTwo hundred and eighty patients with chronic prostatitis complicated by sexual dysfunction were radomized into two groups, on treated with sildenafil, and the other with Quinolone. Results were analyzed by comparing the chronic prostatitis symptoms (CPSI score), sexual dysfunction symptoms (PSFI score) and anxiety symptoms (SAS score) between pre-treatment and post-treatment groups.
RESULTSThe degree of prostatitis-related sexual dysfunction was not correlated with that of prostatitis symptoms. The prostatitis symptoms and sexual function were improved after sildenafil treatment compared with the control (P < 0.05), and anxiety score after treatment was significantly lower than the control (P < 0.05).
CONCLUSIONSildenafil not only works on prostatitis-related sexual dysfunction but also improves the symptoms of prostatitis and anxiety.
